Friday, July 4, 2025 7/4/2025

Development of a closed-loop control system for plasma medicine

Award Number: R01EB029705
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/01/2022
PERIOD OF PERFORMANCE END DATE: 12/31/2025

Group Awards By:

View Award Description

Development of a closed-loop control system for plasma medicine - Project Summary Plasma medicine is a promising, relatively new field that encompasses the discovery and development of biomedical applications for cold plasma (a.k.a. non-thermal, non-equilibrium, or atmospheric plasma). Cold plasma is generated in several forms by using a strong electromagnetic field to ionize gas at atmospheric pressure and ambient temperature. When cold plasma is applied to living cells or tissues, the effects can range from subtle changes in cellular metabolism and function to programmed or necrotic cell death, dependent on plasma properties (or amount of plasma). In therapeutic strategies involving plasma, the dose delivered is an important determinant of a successful treatment. A sub-optimal plasma dose may be ineffective, while a plasma dose in excess of that required to achieve the desired outcome may cause adverse side effects. However, no real-time measure of an effective plasma dose exists. The determination and controlled delivery of a plasma dose, at present, relies on empirical measures of outcome that assess secondary or tertiary effects of plasma hours to days after the exposure. There is a critical need for regulation of cold plasma delivery that uses concurrent measurement of primary plasma effectors (markers) that correlate with biological and clinical outcomes (endpoints) necessary to define plasma dose. The objective of this grant is to develop endpoint detection strategies for plasma-based therapies, using plasma-facilitated wound repair as the endpoint and oxidation-reduction potential (ORP) as the primary detectable marker. The hypothesis is that there is a link between the absolute ORP and cellular responses, allowing us to develop an ORP sensor-based method that monitors the plasma dose and feeds this information in a closed-loop control system. The proposed research is innovative because it will use ORP detection as the basis for a sensor-controlled, closed-loop feedback control system that will regulate plasma delivery as determined by the endpoint outcome. Collaborative investigational and development efforts will combine experience in models of in vivo wound healing (Rutgers University), in vitro models of epithelial wound repair, and plasma biology (Drexel University) with expertise in device engineering and plasma chemistry (North Carolina State University). The proposed research is framed around the following specific aims: (1) Establish correlations between CAP dose ranges, measurable biological parameters and wound healing outcomes using in vivo and in vitro models of wound healing; (2) correlate sensor outputs with cellular responses in the in vitro scratch assay; (3) develop a closed-loop control system for regulated plasma delivery; and (4) challenge and optimize the controller in vitro and in vivo. Our focus on endpoint detection and feedback control for wound healing will facilitate developmental efforts for this particular therapeutic use of plasma, but will also provide a solid foundation for applying endpoint detection to other translational applications of cold plasma, including therapies for dermatological conditions, cancer, and infections by viral and bacterial pathogens.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $485,756 )
2025	2025	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27695	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	4	12/13/2024	NON-COMPETING CONTINUATION	$437,181
2025	2025	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27695	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	4	5/19/2025	NON-COMPETING CONTINUATION	$48,575
														Subtotal = $485,756

Issue Date FY: 2024 ( Subtotal = $463,335 )
2024	2024	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27695	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	002	3	6/26/2024	NON-COMPETING CONTINUATION	$37,823
2024	2024	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27695	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	3	12/13/2023	NON-COMPETING CONTINUATION	$0
2024	2024	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27695	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	12/7/2023	NON-COMPETING CONTINUATION	$425,512
														Subtotal = $463,335

Issue Date FY: 2023 ( Subtotal = $426,885 )
2023	2023	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27607	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	12/21/2022	NON-COMPETING CONTINUATION	$384,198
2023	2023	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27607	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	2	2/1/2023	NON-COMPETING CONTINUATION	$42,687
														Subtotal = $426,885

Issue Date FY: 2022 ( Subtotal = $593,801 )
2022	2022	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27607	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	1	1/31/2022	NEW	$531,778
2022	2022	NORTH CAROLINA STATE UNIVERSITY	2601 WOLF VILLAGE WAY	RALEIGH	NC	27607	WAKE	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	1	6/30/2022	NEW	$62,023
														Subtotal = $593,801

Grand Total All Awards = $1,969,777

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Development of a closed-loop control system for plasma medicine

Award Number: R01EB029705

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/01/2022

PERIOD OF PERFORMANCE END DATE: 12/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer